Hippo (HIPO) Financials

$26.89 -0.11 (-0.41%)

As of 02:58 PM Eastern

Annual Income Statements for Hippo

This table shows Hippo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-142	-371	-333	-273	-41	58
Consolidated Net Income / (Loss)	-141	-368	-327	-263	-29	63
Net Income / (Loss) Continuing Operations	-336	-169	-327	-263	-29	63
Total Pre-Tax Income	-143	-367	-325	-263	-27	63
Total Operating Income	-117	-215	-328	-263	-82	-32
Total Gross Profit	7.00	-35	-42	-51	74	107
Total Revenue	52	91	120	210	372	469
Operating Revenue	52	91	120	210	372	469
Total Cost of Revenue	45	126	161	261	298	361
Operating Cost of Revenue	45	126	161	261	298	361
Total Operating Expenses	124	180	286	211	156	139
Selling, General & Admin Expense	37	49	72	80	71	67
Marketing Expense	69	95	102	80	51	34
Research & Development Expense	18	36	58	47	31	33
Other Operating Expenses / (Income)	-	-	-	-0.80	-0.10	1.00
Restructuring Charge	-	0.00	55	5.50	3.60	5.00
Total Other Income / (Expense), net	-221	47	0.00	0.00	54	95
Other Income / (Expense), net	-195	-	0.00	0.00	54	95
Income Tax Expense	-1.80	0.70	1.30	0.50	1.20	0.70
Net Income / (Loss) Attributable to Noncontrolling Interest	0.10	3.50	6.90	10	12	4.90
Basic Earnings per Share	($1.63)	($34.11)	($14.66)	($11.58)	($1.64)	$2.28
Weighted Average Basic Shares Outstanding	86.90M	10.89M	22.75M	23.58M	24.70M	25.25M
Diluted Earnings per Share	($1.63)	($34.11)	($14.66)	($11.58)	($1.64)	$2.22
Weighted Average Diluted Shares Outstanding	86.90M	10.89M	22.75M	23.58M	24.70M	26.01M
Weighted Average Basic & Diluted Shares Outstanding	-	566.27M	23.31M	24.31M	25.08M	25.97M

This table shows Hippo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-53	-42	-36	-41	-8.50	44	-48	1.30	98	6.00	7.10
Consolidated Net Income / (Loss)	-50	-39	-33	-37	-5.20	47	-45	3.90	98	6.00	7.10
Net Income / (Loss) Continuing Operations	-50	-39	-33	-37	-5.20	47	-45	3.90	98	6.00	7.10
Total Pre-Tax Income	-51	-39	-33	-37	-5.20	47	-46	4.00	98	6.80	7.20
Total Operating Income	-51	-40	-33	-37	-13	1.00	-46	4.00	3.10	6.80	7.20
Total Gross Profit	0.90	9.50	12	4.70	21	37	-12	40	40	40	39
Total Revenue	58	65	85	90	96	102	110	117	121	120	122
Operating Revenue	58	65	85	90	96	102	110	117	121	120	122
Total Cost of Revenue	57	55	73	85	74	65	123	77	80	81	82
Operating Cost of Revenue	57	55	73	85	74	65	123	77	80	81	82
Total Operating Expenses	52	50	45	41	35	36	33	36	37	33	32
Selling, General & Admin Expense	21	18	18	20	15	17	17	17	17	17	16
Marketing Expense	19	16	14	13	13	11	8.90	9.20	8.00	7.40	6.30
Research & Development Expense	12	10	8.30	7.80	7.00	7.60	8.10	8.10	8.00	8.30	9.40
Other Operating Expenses / (Income)	0.00	-	0.00	0.10	-0.10	-0.10	-0.20	0.10	0.80	0.30	0.00
Total Other Income / (Expense), net	0.00	-	0.00	0.00	8.20	46	0.00	0.00	95	-	0.00
Income Tax Expense	-0.30	0.30	0.20	0.70	0.00	0.30	-0.20	0.10	0.00	0.80	0.10
Net Income / (Loss) Attributable to Noncontrolling Interest	2.80	3.00	2.60	3.30	3.30	2.70	2.30	2.60	0.00	-	0.00
Basic Earnings per Share	($2.24)	($1.80)	($1.47)	($1.64)	($0.34)	$1.81	($1.91)	$0.05	$3.90	$0.24	$0.27
Weighted Average Basic Shares Outstanding	23.73M	23.58M	24.23M	24.63M	25.07M	24.70M	24.98M	25.34M	25.18M	25.25M	25.84M
Diluted Earnings per Share	($2.24)	($1.80)	($1.47)	($1.64)	($0.34)	$1.81	($1.91)	$0.05	$3.77	$0.31	$0.27
Weighted Average Diluted Shares Outstanding	23.73M	23.58M	24.23M	24.63M	25.07M	24.70M	24.98M	26.02M	26.03M	26.01M	26.35M
Weighted Average Basic & Diluted Shares Outstanding	23.89M	24.31M	24.43M	24.36M	-	25.08M	25.16M	25.03M	25.34M	25.97M	26.04M

This table details how cash moves in and out of Hippo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	450	326	-574	-49	38	17
Net Cash From Operating Activities	-65	-125	-162	-92	48	9.20
Net Cash From Continuing Operating Activities	-65	-125	-162	-92	48	9.20
Net Income / (Loss) Continuing Operations	-141	-368	-327	-263	-29	63
Consolidated Net Income / (Loss)	-141	-368	-327	-263	-29	63
Depreciation Expense	6.70	11	15	20	23	20
Non-Cash Adjustments To Reconcile Net Income	78	241	180	188	89	20
Changes in Operating Assets and Liabilities, net	-8.20	-29	-30	-37	-36	-94
Net Cash From Investing Activities	-2.30	-30	-406	58	30	-11
Net Cash From Continuing Investing Activities	-2.30	-30	-406	58	30	-11
Purchase of Property, Plant & Equipment	-9.40	-14	-20	-47	-12	-13
Purchase of Investments	-17	-26	-793	-410	-368	-426
Divestitures	-	-	0.00	0.00	67	66
Sale and/or Maturity of Investments	108	17	409	517	337	362
Other Investing Activities, net	0.00	-2.90	-2.00	-3.20	6.00	0.00
Net Cash From Financing Activities	518	481	-6.80	-15	-40	19
Net Cash From Continuing Financing Activities	518	481	-6.80	-15	-40	19
Repurchase of Common Equity	-	-	0.00	-1.80	-16	-15
Payment of Dividends	-	-	-5.30	-9.60	-20	-8.10
Issuance of Debt	-	-	-	0.00	0.00	48
Issuance of Common Equity	-	-	4.10	2.80	6.70	3.80
Other Financing Activities, net	-1.50	482	-5.60	-6.00	-11	-9.80

This table details how cash moves in and out of Hippo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	31	-74	51	-43	-36	56	-17	21	30	-16	46
Net Cash From Operating Activities	1.10	-49	18	-11	47	-6.40	-36	25	17	3.20	8.50
Net Cash From Continuing Operating Activities	1.10	-49	0.00	-11	-	48	0.00	-	-	9.20	0.00
Net Income / (Loss) Continuing Operations	-50	-39	0.00	-37	-	-29	0.00	-	-	63	0.00
Net Cash From Investing Activities	31	-22	59	-28	-28	28	-11	-22	47	-26	43
Net Cash From Continuing Investing Activities	31	-22	59	-28	-28	28	-11	-22	47	-26	43
Purchase of Property, Plant & Equipment	-4.70	-4.50	-3.40	-3.80	-3.40	-1.40	-2.90	-3.40	-3.50	-3.50	-3.20
Purchase of Investments	-84	-119	-55	-84	-105	-124	-66	-132	-102	-126	-95
Sale and/or Maturity of Investments	119	104	117	60	61	100	58	114	87	104	115
Other Investing Activities, net	-	-2.30	-	-	-	5.80	0.00	-	-	-	25
Net Cash From Financing Activities	-0.90	-3.80	-8.00	-4.40	-8.20	-20	-6.00	43	-18	0.40	3.70
Net Cash From Continuing Financing Activities	-1.00	-3.70	-8.00	-4.40	-8.20	-20	-6.00	43	-18	0.40	3.70
Repayment of Debt	-	-	-	-	-	-	-1.00	-	-	-	2.70
Payment of Dividends	-0.10	-3.10	-7.60	-2.70	-6.30	-3.80	-2.50	-4.10	0.10	-0.60	0.00
Issuance of Common Equity	0.50	0.40	1.00	1.20	0.80	3.70	1.00	1.30	0.50	1.00	1.00
Other Financing Activities, net	-1.40	-1.00	-1.40	-2.90	-2.70	-3.80	-3.50	-2.30	-4.00	-	0.00

This table presents Hippo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	979	1,643	1,569	1,525	1,543	1,906
Total Current Assets	489	841	627	287	365	468
Cash & Equivalents	452	776	195	142	198	218
Accounts Receivable	37	57	107	145	167	250
Plant, Property, & Equipment, net	0.00	0.00	0.00	162	206	293
Plant, Property & Equipment, gross	-	-	-	162	206	293
Total Noncurrent Assets	490	802	942	1,076	973	1,144
Long-Term Investments	56	55	121	187	168	153
Intangible Assets	49	58	66	76	65	57
Other Noncurrent Operating Assets	338	635	756	813	740	934
Total Liabilities & Shareholders' Equity	979	1,643	1,569	1,525	1,543	1,906
Total Liabilities	834	781	975	1,140	1,178	1,469
Total Current Liabilities	234	516	629	696	686	806
Accrued Expenses	43	95	128	114	87	81
Other Current Liabilities	191	420	501	583	599	725
Total Noncurrent Liabilities	600	265	346	444	492	664
Long-Term Debt	273	-	-	-	0.00	48
Other Noncurrent Operating Liabilities	327	265	346	444	492	616
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-200	862	594	385	365	436
Total Preferred & Common Equity	-200	860	590	378	362	436
Total Common Equity	-200	860	590	378	362	436
Common Stock	57	1,488	1,558	1,615	1,640	1,652
Retained Earnings	-257	-628	-961	-1,234	-1,275	-1,217
Accumulated Other Comprehensive Income / (Loss)	0.10	-0.70	-7.00	-2.90	-2.70	1.80

This table presents Hippo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2022	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	6/30/2022	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	1,629	1,630	1,605	1,681	1,647	1,496	1,545	1,540	1,706	1,874	2,062
Total Current Assets	696	658	613	577	562	502	743	314	426	484	558
Cash & Equivalents	278	347	189	200	228	223	191	141	199	248	275
Accounts Receivable	67	90	134	148	145	154	158	173	227	237	282
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00	0.00	212	237	246	299
Plant, Property & Equipment, gross	-	-	-	-	-	-	-	212	237	246	299
Total Noncurrent Assets	934	972	992	1,104	1,085	994	802	1,015	1,043	1,144	1,206
Long-Term Investments	103	109	141	136	142	163	-	175	168	175	125
Intangible Assets	63	65	67	69	71	75	74	64	62	57	56
Other Noncurrent Operating Assets	714	798	784	899	873	757	728	776	814	912	1,025
Total Liabilities & Shareholders' Equity	1,629	1,630	1,605	1,681	1,647	1,496	1,545	1,540	1,706	1,874	2,062
Total Liabilities	878	991	1,062	1,234	1,236	1,142	1,215	1,215	1,372	1,452	1,613
Total Current Liabilities	582	661	687	798	776	705	710	730	780	802	911
Accrued Expenses	121	124	133	128	125	105	98	91	77	85	72
Other Current Liabilities	461	537	555	670	651	600	612	639	692	717	839
Total Noncurrent Liabilities	296	330	374	436	460	436	505	485	593	650	703
Long-Term Debt	-	-	-	-	-	-	-	-	48	48	48
Other Noncurrent Operating Liabilities	296	330	374	436	460	436	505	485	545	602	655
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	751	639	543	447	411	355	330	326	334	422	449
Total Preferred & Common Equity	749	635	538	446	407	351	326	323	333	422	449
Total Common Equity	749	635	538	446	407	351	326	323	333	422	449
Common Stock	1,523	1,541	1,575	1,591	1,606	1,625	1,645	1,646	1,654	1,643	1,659
Retained Earnings	-769	-898	-1,031	-1,139	-1,192	-1,270	-1,319	-1,323	-1,321	-1,223	-1,210
Accumulated Other Comprehensive Income / (Loss)	-4.90	-7.80	-5.30	-6.40	-7.10	-3.40	0.50	-0.60	0.10	1.40	-0.60

This table displays calculated financial ratios and metrics derived from Hippo's official financial filings.

Metric	2020	2021	2022	2023	2024	2025
Period end date	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	-	-	-	-	-	25,335,179.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	25,335,179.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	2.28
Growth Metrics	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	-82	-151	-229	-184	-57	-31
Return On Investment Capital (ROIC_SIMPLE)	-	-	-38.65%	-47.91%	-15.70%	-6.48%
Earnings before Interest and Taxes (EBIT)	-312	-215	-328	-263	-28	63
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-305	-184	-313	-244	-4.30	84
Valuation Ratios	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-263	-160	-287	-1.83	181
Efficiency Ratios	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	-90	22	-47	56	0.00	-212
Increase / (Decrease) in Invested Capital	0.00	112	-69	102	-56	-212
Book Value per Share	($2.30)	$1.53	$25.58	$15.82	$14.86	$17.21
Tangible Book Value per Share	($3.41)	$1.33	$22.73	$12.65	$12.19	$14.97
Total Capital	418	862	594	385	365	484
Total Debt	273	0.00	0.00	0.00	0.00	48
Total Long-Term Debt	273	0.00	0.00	0.00	0.00	48
Net Debt	-235	-840	-640	-329	-365	-648
Capital Expenditures (CapEx)	9.40	14	20	47	12	13
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-197	-459	-522	-551	-519	-251
Debt-free Net Working Capital (DFNWC)	255	326	-2.60	-409	-321	445
Net Working Capital (NWC)	255	326	-2.60	-409	-321	445
Net Nonoperating Expense (NNE)	59	217	97	79	-29	-94
Net Nonoperating Obligations (NNO)	-235	-840	-640	-329	-365	-648
Total Depreciation and Amortization (D&A)	6.70	31	15	20	23	20
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($34.00)	($14.66)	($11.58)	($1.64)	$2.28
Adjusted Weighted Average Basic Shares Outstanding	0.00	10.89M	22.75M	23.58M	24.70M	25.25M
Adjusted Diluted Earnings per Share	$0.00	($34.00)	($14.66)	($11.58)	($1.64)	$2.22
Adjusted Weighted Average Diluted Shares Outstanding	0.00	10.89M	22.75M	23.58M	24.70M	26.01M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	22.65M	23.31M	24.31M	25.08M	25.97M
Normalized Net Operating Profit after Tax (NOPAT)	-82	-151	-191	-180	-55	-26
Debt Service Ratios	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from Hippo's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	9/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	24,359,710.00	-	-	-	25,335,179.00	25,970,978.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	24,359,710.00	-	-	-	25,335,179.00	25,970,978.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	1.81	-	-	-	0.24	0.27
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	87.95%	80.17%	113.82%	100.21%	65.51%	-	29.61%	30.92%	26.28%	-	10.15%
EBITDA Growth	62.97%	40.51%	56.80%	100.70%	88.62%	-	-38.60%	110.96%	1,986.54%	-	115.79%
EBIT Growth	60.22%	35.68%	51.26%	95.05%	89.72%	-	-38.60%	110.96%	1,986.54%	-	115.79%
NOPAT Growth	60.25%	34.21%	51.26%	95.05%	73.52%	-	-38.60%	115.26%	133.05%	-	122.24%
Net Income Growth	60.55%	34.88%	51.40%	95.06%	89.66%	-	-37.16%	110.48%	1,986.54%	-	115.64%
EPS Growth	60.42%	35.02%	51.16%	92.62%	84.82%	-	-29.93%	103.05%	1,208.82%	-	114.14%
Operating Cash Flow Growth	102.56%	-61.13%	149.58%	-13.98%	4,154.55%	-	-301.13%	333.02%	-63.89%	-	123.88%
Free Cash Flow Firm Growth	3,250.68%	-597.67%	-16.35%	110.14%	-313.25%	-	-454.45%	-347.43%	71.95%	-	59.71%
Invested Capital Growth	-284.07%	218.34%	-101.81%	-116.92%	0.00%	-	106.03%	110.11%	0.00%	-	921.28%
Revenue Q/Q Growth	20.96%	11.79%	31.94%	12.22%	6.58%	-	0.00%	6.35%	2.81%	-	0.91%
EBITDA Q/Q Growth	54.21%	23.85%	21.55%	102.56%	85.75%	-	0.00%	108.77%	2,352.50%	-	5.88%
EBIT Q/Q Growth	51.81%	20.55%	18.16%	84.19%	85.75%	-	0.00%	108.77%	2,352.50%	-	5.88%
NOPAT Q/Q Growth	51.81%	20.55%	18.16%	84.19%	63.29%	-	0.00%	112.22%	-20.51%	-	18.33%
Net Income Q/Q Growth	52.19%	21.67%	15.99%	84.29%	86.02%	-	0.00%	108.59%	2,415.38%	-	18.33%
EPS Q/Q Growth	51.41%	19.64%	18.33%	76.87%	79.27%	-	0.00%	102.62%	7,440.00%	-	-12.90%
Operating Cash Flow Q/Q Growth	111.83%	-4,509.09%	136.49%	-159.89%	541.51%	-	0.00%	169.38%	-31.58%	-	165.63%
Free Cash Flow Firm Q/Q Growth	15.20%	-277.90%	-33.85%	140.45%	-239.78%	-	0.00%	-40.38%	84.15%	-	25.84%
Invested Capital Q/Q Growth	-25.09%	137.73%	2.01%	-63.53%	100.00%	-	0.00%	174.47%	82.17%	-	-15.19%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	1.56%	14.73%	13.75%	22.30%	22.30%	-	-11.15%	34.10%	33.33%	-	32.18%
EBITDA Margin	-79.20%	-53.95%	-32.08%	0.73%	-5.45%	-	-41.34%	3.41%	81.34%	-	5.93%
Operating Margin	-87.70%	-62.33%	-38.66%	-5.45%	-14.03%	-	-41.34%	3.41%	2.57%	-	5.93%
EBIT Margin	-87.70%	-62.33%	-38.66%	-5.45%	-5.45%	-	-41.34%	3.41%	81.34%	-	5.93%
Profit (Net Income) Margin	-87.18%	-61.09%	-38.90%	-5.45%	-5.45%	-	-41.16%	3.32%	81.34%	-	5.84%
Tax Burden Percent	99.41%	100.77%	100.61%	100.00%	100.00%	-	99.56%	97.50%	100.00%	-	98.61%
Interest Burden Percent	100.00%	97.26%	100.00%	100.00%	100.00%	-	100.00%	100.00%	100.00%	-	100.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	2.50%	0.00%	-	1.39%
Return on Invested Capital (ROIC)	0.00%	-2,127.62%	0.00%	0.00%	0.00%	-	0.00%	0.00%	49.23%	-	53.20%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-2,125.30%	0.00%	0.00%	0.00%	-	0.00%	0.00%	-1.50%	-	53.20%
Return on Net Nonoperating Assets (RNNOA)	0.00%	2,106.61%	0.00%	0.00%	0.00%	-	0.00%	0.00%	1.33%	-	-45.96%
Return on Equity (ROE)	-54.10%	-21.01%	-50.79%	-32.94%	0.00%	-	-12.02%	0.06%	50.57%	-	7.24%
Cash Return on Invested Capital (CROIC)	0.00%	-516.59%	0.00%	0.00%	0.00%	-	-2,464.04%	-1,193.60%	-359.69%	-	-124.63%
Operating Return on Assets (OROA)	-9.69%	-8.45%	-6.36%	-1.02%	0.00%	-	-10.82%	0.89%	19.54%	-	1.58%
Return on Assets (ROA)	-9.63%	-8.28%	-6.40%	-1.02%	0.00%	-	-10.77%	0.87%	19.54%	-	1.56%
Return on Common Equity (ROCE)	-53.67%	-20.78%	-50.32%	-32.73%	0.00%	-	-11.91%	0.06%	50.57%	-	7.21%
Return on Equity Simple (ROE_SIMPLE)	-69.80%	0.00%	-64.92%	-39.22%	0.00%	-	-12.67%	0.00%	0.00%	-	0.00%
Net Operating Profit after Tax (NOPAT)	-35	-28	-23	-3.64	-9.38	0.99	-32	3.90	3.10	6.00	7.10
NOPAT Margin	-61.39%	-43.63%	-27.06%	-3.81%	-9.82%	-	-28.94%	3.32%	2.57%	-	5.84%
Net Nonoperating Expense Percent (NNEP)	-2.41%	-2.32%	-1.78%	-0.27%	0.00%	-	-3.26%	0.00%	50.73%	-	0.00%
Return On Investment Capital (ROIC_SIMPLE)	-	-7.31%	-	-	-	0.27%	-9.80%	1.02%	0.66%	1.24%	1.43%
Cost of Revenue to Revenue	98.44%	85.27%	86.25%	77.70%	77.70%	-	111.15%	65.90%	66.67%	-	67.82%
SG&A Expenses to Revenue	35.88%	27.29%	21.50%	16.02%	16.02%	-	14.96%	14.83%	13.68%	-	13.33%
R&D to Revenue	20.62%	16.12%	9.75%	7.33%	7.33%	-	7.34%	6.91%	6.63%	-	7.74%
Operating Expenses to Revenue	89.25%	77.05%	52.41%	27.75%	36.34%	-	30.19%	30.69%	30.76%	-	26.26%
Earnings before Interest and Taxes (EBIT)	-51	-40	-33	-5.20	-5.20	1.00	-46	4.00	98	6.80	7.20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-46	-35	-27	0.70	-5.20	1.00	-46	4.00	98	6.80	7.20
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.46	0.58	1.26	1.29	0.00	-	1.99	2.11	2.15	-	1.51
Price to Tangible Book Value (P/TBV)	0.56	0.72	1.61	1.67	0.00	-	2.47	2.59	2.48	-	1.72
Price to Revenue (P/Rev)	1.04	1.04	1.74	1.39	1.26	-	1.61	1.65	2.01	-	1.41
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	9.44	-	6.02
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%	0.00%	-	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%	10.60%	-	16.62%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	-	34.86	14.94	11.29	-	3.38
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	-	0.82	0.91	1.18	-	0.68
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	-	15.36
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	-	15.36
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	-	15.49
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	-	0.00	13.07	0.00	-	6.08
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	-	0.00	0.14	0.11	-	0.11
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	-	0.00	0.14	0.11	-	0.11
Financial Leverage	-1.18	-0.99	-1.26	-1.48	0.00	-	-1.22	-1.35	-0.89	-	-0.86
Leverage Ratio	3.12	3.16	3.45	4.15	0.00	-	4.46	4.90	4.45	-	4.65
Compound Leverage Factor	3.12	3.08	3.45	4.15	0.00	-	4.46	4.90	4.45	-	4.65
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	12.54%	10.20%	-	9.65%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%	0.00%	-	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	12.54%	10.20%	-	9.65%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%	0.00%	0.00%	-	0.00%
Noncontrolling Interests to Total Capital	1.05%	1.77%	1.01%	1.12%	0.00%	-	0.89%	0.42%	0.00%	-	0.00%
Common Equity to Total Capital	98.95%	98.23%	98.99%	98.88%	0.00%	-	99.11%	87.04%	89.80%	-	90.35%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	-	0.00	-0.89	-1.27	-	2.27
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	-	0.00	5.89	9.96	-	-16.72
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	-	0.00	-0.89	-1.27	-	2.27
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	-	0.00	-1.77	-1.28	-	2.29
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	-	0.00	11.79	9.98	-	-16.86
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	-	0.00	-1.77	-1.28	-	2.29
Altman Z-Score	-1.07	-1.29	-1.02	-0.78	0.00	-	-1.05	-0.77	-0.33	-	-0.53
Noncontrolling Interest Sharing Ratio	0.79%	1.06%	0.92%	0.66%	0.00%	-	0.96%	0.80%	0.00%	-	0.37%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.72	0.41	0.71	1.05	0.00	-	0.43	0.55	0.60	-	0.61
Quick Ratio	0.72	0.41	0.71	0.99	0.00	-	0.43	0.55	0.60	-	0.61
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	73	-131	56	134	-156	56	-197	-277	-44	218	-80
Operating Cash Flow to CapEx	23.40%	-1,077.78%	520.59%	-278.95%	1,376.47%	-	-1,227.59%	726.47%	482.86%	-	265.63%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.11	0.14	0.16	0.19	0.00	-	0.26	0.26	0.24	-	0.27
Accounts Receivable Turnover	1.54	1.66	1.77	1.98	0.00	-	2.43	2.21	1.90	-	2.11
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	1.83	-	1.88
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Days Sales Outstanding (DSO)	237.15	219.66	205.69	184.43	0.00	-	150.02	165.28	191.95	-	173.03
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Cash Conversion Cycle (CCC)	237.15	219.66	205.69	184.43	0.00	-	150.02	165.28	191.95	-	173.03
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	-147	56	-156	-255	0.00	0.00	9.40	26	47	-212	96
Invested Capital Turnover	-1.95	48.77	-2.19	-1.62	0.00	-	-5.42	-3.71	19.15	-	9.10
Increase / (Decrease) in Invested Capital	-109	102	-79	-138	147	-56	165	281	47	-212	87
Enterprise Value (EV)	-365	-105	-63	-161	0.00	-	328	385	531	-	324
Market Capitalization	189	218	444	421	421	-	641	703	905	-	677
Book Value per Share	$17.20	$15.82	$14.45	$13.10	$0.00	$14.86	$12.87	$13.22	$16.84	$17.21	$17.28
Tangible Book Value per Share	$14.22	$12.65	$11.36	$10.13	$0.00	$12.19	$10.34	$10.77	$14.55	$14.97	$15.12
Total Capital	411	385	355	330	0.00	365	326	382	469	484	497
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	48	48	48	48
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	48	48	48	48
Net Debt	-558	-329	-511	-585	0.00	-365	-316	-319	-375	-648	-353
Capital Expenditures (CapEx)	4.70	4.50	3.40	3.80	3.40	1.40	2.90	3.40	3.50	3.50	3.20
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-631	-551	-551	-553	0.00	-519	-557	-553	-565	-251	-629
Debt-free Net Working Capital (DFNWC)	-214	-409	-203	33	0.00	-321	-416	-354	-317	445	-353
Net Working Capital (NWC)	-214	-409	-203	33	0.00	-321	-416	-354	-317	445	-353
Net Nonoperating Expense (NNE)	15	11	10	1.56	-4.18	-46	13	0.00	-95	0.00	0.00
Net Nonoperating Obligations (NNO)	-558	-329	-511	-585	0.00	-365	-316	-308	-375	-648	-353
Total Depreciation and Amortization (D&A)	4.90	5.40	5.60	5.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt-free, Cash-free Net Working Capital to Revenue	-348.34%	-262.71%	-216.24%	-182.50%	0.00%	-	-140.25%	-130.00%	-125.55%	-	-131.01%
Debt-free Net Working Capital to Revenue	-118.01%	-194.95%	-79.73%	10.77%	0.00%	-	-104.78%	-83.20%	-70.52%	-	-73.61%
Net Working Capital to Revenue	-118.01%	-194.95%	-79.73%	10.77%	0.00%	-	-104.78%	-83.20%	-70.52%	-	-73.61%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($2.24)	($1.80)	($1.47)	($0.34)	$0.00	$1.81	($1.91)	$0.05	$3.90	$0.24	$0.27
Adjusted Weighted Average Basic Shares Outstanding	23.73M	23.58M	24.23M	25.07M	0.00	24.70M	24.98M	25.34M	25.18M	25.25M	25.84M
Adjusted Diluted Earnings per Share	($2.24)	($1.80)	($1.47)	($0.34)	$0.00	$1.81	($1.91)	$0.05	$3.77	$0.31	$0.27
Adjusted Weighted Average Diluted Shares Outstanding	23.73M	23.58M	24.23M	25.07M	0.00	24.70M	24.98M	26.02M	26.03M	26.01M	26.35M
Adjusted Basic & Diluted Earnings per Share	$0.00	($1.80)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	23.89M	24.31M	24.43M	24.36M	0.00	25.08M	25.16M	25.03M	25.34M	25.97M	26.04M
Normalized Net Operating Profit after Tax (NOPAT)	-35	-24	-21	-9.38	-9.38	0.99	-32	5.07	4.83	6.00	7.10
Normalized NOPAT Margin	-61.39%	-37.66%	-24.10%	-9.82%	-9.82%	-	-28.94%	4.32%	4.01%	-	5.84%
Pre Tax Income Margin	-87.70%	-60.62%	-38.66%	-5.45%	-5.45%	-	-41.34%	3.41%	81.34%	-	5.93%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-3.38%	-3.65%	-7.28%	-10.55%	-17.15%	-	-39.85%	8,850.00%	10.92%	-	4.87%
Augmented Payout Ratio	-4.01%	-4.33%	-7.98%	-10.55%	-17.15%	-	-39.85%	8,850.00%	40.00%	-	4.87%

Financials Breakdown Chart

Key Financial Trends

Hippo (NYSE:HIPO) has shown a growing top line in the last four years, with margin improvement and a shift toward cash generation in 2025. Below are the key takeaways drawn from the quarterly income statements, cash flow statements, and balance sheets provided (Q1 2022 through Q4 2025, focusing on the most recent four years). The bullets are ordered to highlight positives first, then neutral items, then negatives.

Strong revenue growth over the period. Operating revenue rose from about $29 million in 2022 to roughly $120 million by Q4 2025, showing a clear top-line expansion as the company scales.
Gross margin improvement into 2025. Gross margin improved from around 9% in late 2024 to roughly 33% in Q4 2025, indicating favorable mix or pricing improvements as revenue grew.
Operating profitability returns in late 2025. Operating income turned positive in Q3 2025 and continued rising into Q4 2025 (about $3.1 million in Q3 2025 and $6.8 million in Q4 2025), signaling a narrowing of operating losses.
Consistent cash generation in mid-2025. Net cash from operating activities was notably positive in Q3 2025 (approximately $16.9 million) and remained positive in Q4 2025 (about $3.2 million), highlighting improved cash flow dynamics.
Liquidity improving with a higher cash stash. Cash and equivalents rose to around $248 million by Q3 2025, up from roughly $199 million in Q2 2025, supporting liquidity for growth initiatives.
Manageable debt profile supports balance sheet strength. Long-term debt remained relatively small and stable around $48 million through 2025, helping preserve liquidity as operations scale.
One-time non-operating gain in Q3 2025. A sizable boost from other income/expense in Q3 2025 (non-operating) contributed to net income that quarter, but it is not indicative of ongoing operating profitability.
Investing activity shows aggressive portfolio activity in 2025. The company engaged in meaningful investment purchases and sales in 2025 (for example, substantial investments net outflows in Q4 2025), signaling a growth-oriented capital allocation approach rather than a pure recurring operating cash flow signal.
Net income remains negative in several quarters. Despite top-line growth, a number of quarters in 2025 still show negative net income, underscoring ongoing profitability challenges outside the latest positive quarters.
Ongoing equity dilution through small issuances. The company engaged in multiple modest equity issuances across 2025 (approximately $1–1.3 million per quarter), which can exert dilution pressure on existing shareholders unless offset by high growth and profits.

05/12/26 02:59 PM ETAI Generated. May Contain Errors.

Hippo Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Hippo's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Hippo's net income appears to be on a downward trend, with a most recent value of $62.60 million in 2025, falling from -$141.40 million in 2020. The previous period was -$28.60 million in 2024. Check out Hippo's forecast to explore projected trends and price targets.

Hippo's total operating income in 2025 was -$31.70 million, based on the following breakdown:

Total Gross Profit: $107.40 million
Total Operating Expenses: $139.10 million

Over the last 5 years, Hippo's total revenue changed from $51.60 million in 2020 to $468.60 million in 2025, a change of 808.1%.

Hippo's total liabilities were at $1.47 billion at the end of 2025, a 24.7% increase from 2024, and a 76.2% increase since 2020.

In the past 5 years, Hippo's cash and equivalents has ranged from $142.10 million in 2023 to $775.60 million in 2021, and is currently $218.30 million as of their latest financial filing in 2025.

Over the last 5 years, Hippo's book value per share changed from -2.30 in 2020 to 17.21 in 2025, a change of -849.4%.

Related Companies

Financial statements for NYSE:HIPO last updated on 5/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hippo (HIPO) Financials

Financials Breakdown Chart

Key Financial Trends

Hippo Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hippo (HIPO) Financials

Annual Income Statements for Hippo

Quarterly Income Statements for Hippo

Annual Cash Flow Statements for Hippo

Quarterly Cash Flow Statements for Hippo

Annual Balance Sheets for Hippo

Quarterly Balance Sheets for Hippo

Annual Metrics And Ratios for Hippo

Quarterly Metrics And Ratios for Hippo

Financials Breakdown Chart

Key Financial Trends

Hippo Financials - Frequently Asked Questions

When does Hippo's fiscal year end?

How has Hippo's net income changed over the last 5 years?

What is Hippo's operating income?

How has Hippo's revenue changed over the last 5 years?

How much debt does Hippo have?

How much cash does Hippo have?

How has Hippo's book value per share changed over the last 5 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools